Atrial Fibrillation and Flutter Clinical Trial
Official title:
Impact of Education Level on Clinical Outcomes in Self-INR Managed Patients on Longterm Warfarin: A Single-center Randomized Controlled Study
Oral anticoagulation (OAC) is indicated in a wide variety of clinical conditions including atrial fibrillation (AF), mechanical valve prosthesis (MVP), deep vein thrombosis and pulmonary embolism. Although direct OAC has replaced vitamin K antagonists (VKA) in non-valvular AF due to lower bleeding risk, it's still recommended to use VKA specifically in cases of valvular AF, MVP and anti-phospholipid syndrome. VKA has a narrow therapeutic range and multiple drug interactions causing unpredicted pharmacodynamics. This requires regular monitoring of the international normalized ratio (INR) level to ensure it's in the target therapeutic range and prevent extreme values that may result in thrombo-embolic events or sometimes fatal bleeding. Self-INR monitoring and management have emerged recently as a safe cost-effective alternative to standard management, with evidence of tighter control of INR, reduction of thrombo-embolic events, and improving treatment-related quality of life. However, there are no specific criteria for patient selection. Whether the level of education and other social factors would affect the outcomes of self-management is still not clear. Owing to the wide geographical area served by Aswan Heart Center, many patients have to cover long distances to follow up their INR and seek medical advice regarding adequate dose modification. This may result in reluctance and non-compliance to clinic visits and INR testing. Proper education, training and providing an alternative near place to measure the INR and self-adjust warfarin dose is expected to improve patient adherence and compliance.
Status | Recruiting |
Enrollment | 586 |
Est. completion date | December 1, 2024 |
Est. primary completion date | December 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult patients above 18 years who are indicated for long term VKA and has been on VKA for more than 6 months. Exclusion Criteria: 1. Refusal to join the study. 2. History of prior life-threatening bleeding or thrombo-embolic events. 3. Illiterate patients with no caregivers living at the same home. |
Country | Name | City | State |
---|---|---|---|
Egypt | Aswan Heart Centre | Aswan |
Lead Sponsor | Collaborator |
---|---|
Cairo University | Magdi Yacoub Heart Foundation |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time and proportion of INR in therapeutic range | Time in therapeutic range and percentage of test results in therapeutic range | 6 months | |
Secondary | All-cause mortality | Death from any cause | 6 months | |
Secondary | Thrombo-embolic events | Stroke, valve thrombosis or peripheral embolism | 6 months | |
Secondary | Major bleeding | Overt bleeding that requires medical intervention or hospitalization | 6 months | |
Secondary | Minor bleeding | Self-controlled bleeding that doesn't need seeking medical advice | 6 months | |
Secondary | Frequency of testing | Number of tests per specific time range | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT06056557 -
Versatility of a Circular Multielectrode Catheter in the Individualized Recognition & Treatment of Atrial Fibrillation and Related Arrhythmias Using Pulsed Field Energy
|
N/A | |
Recruiting |
NCT03862859 -
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
|
Phase 4 | |
Completed |
NCT03788044 -
Effect of Targeted Education for Atrial Fibrillation Patients (Application Substudy)
|
N/A | |
Completed |
NCT03707873 -
Effect of Targeted Education for Atrial Fibrillation Patients
|
N/A | |
Active, not recruiting |
NCT05009225 -
Clinical Decision Support for Atrial Fibrillation and Flutter
|
||
Recruiting |
NCT02623049 -
Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation
|
||
Completed |
NCT05509517 -
A Clinical Trial of the Use of Remote Heart Rhythm Monitoring With a Smartphone After Cardiac Surgery
|
N/A | |
Completed |
NCT03377465 -
Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis
|
N/A | |
Completed |
NCT03243604 -
cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study
|
||
Enrolling by invitation |
NCT06452823 -
Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization
|
||
Recruiting |
NCT04855890 -
HIgh Power Short Duration Radiofrequency Ablation or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation
|
N/A | |
Active, not recruiting |
NCT03110627 -
Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead
|
N/A | |
Completed |
NCT03911986 -
Risk-Based Screening for the Evaluation of Atrial Fibrillation Trial
|
N/A | |
Completed |
NCT03472495 -
Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial
|
Phase 4 | |
Recruiting |
NCT04438395 -
Dielectric Tissue Imaging in Cavotricuspid Isthmus Ablation
|
||
Completed |
NCT02344901 -
ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)
|
N/A | |
Completed |
NCT02273609 -
INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA)
|
N/A | |
Recruiting |
NCT05159180 -
Development of a New Impedance Mapping System for Ablation of Atrial Arrhythmias in Patients
|
||
Active, not recruiting |
NCT03488420 -
Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE
|
||
Completed |
NCT05008601 -
Aino ECG Ambulatory Study
|